- Home
- GELS
GELS
GELTEQ LIMITED
as 04-24-2025 12:37pm EST
Stocks
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
| Founded: | 2018 | Country: | Australia |
| Employees: | N/A | City: | N/A |
| Market Cap: | 7.7M | IPO Year: | 2024 |
| Target Price: | N/A | AVG Volume (30 days): | 4.6M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.29 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.77 - $5.50 | Next Earning Date: | 02-15-2025 |
| Revenue: | $95,618 | Revenue Growth: | -61.48% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest GELTEQ LIMITED News
GELS Breaking Stock News: Dive into GELS Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 months ago
Gelteq’s Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand
GlobeNewswire
3 months ago
Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC
GlobeNewswire
3 months ago
Gelteq Appoints Matthew Jones as Head of Sports Performance
GlobeNewswire
4 months ago
Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
GlobeNewswire
4 months ago
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug
GlobeNewswire
5 months ago
Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
GlobeNewswire
5 months ago
Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
GlobeNewswire
5 months ago
Gelteq Announces 400,000 Units Enter into Production in November 2024
Compare GELS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GELS GELTEQ LIMITED - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.